Jazz Pharmaceuticals plc
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $2.83B | $4.82B | $347.0M |
| Jun 2017 | $2.60B | $4.80B | $239.2M |
| Sep 2017 | $2.53B | $5.00B | $252.6M |
| Dec 2017 | $2.41B | $5.12B | $386.0M |
| Mar 2018 | $2.50B | $5.29B | $453.2M |
| Jun 2018 | $2.48B | $5.35B | $485.1M |
| Sep 2018 | $2.46B | $5.49B | $499.0M |
| Dec 2018 | $2.45B | $5.20B | $309.6M |
| Mar 2019 | $2.55B | $5.28B | $547.5M |
| Jun 2019 | $2.51B | $5.49B | $637.7M |
| Sep 2019 | $2.47B | $5.53B | $795.2M |
| Dec 2019 | $2.43B | $5.54B | $637.3M |
| Mar 2020 | $2.41B | $5.22B | $701.6M |
| Jun 2020 | $2.92B | $6.07B | $786.1M |
| Sep 2020 | $2.91B | $6.29B | $741.9M |
| Dec 2020 | $2.88B | $6.54B | $1.06B |
| Mar 2021 | $2.96B | $6.76B | $2.10B |
| Jun 2021 | $9.08B | $13.21B | $891.4M |
| Sep 2021 | $8.54B | $12.48B | $671.8M |
| Dec 2021 | $8.33B | $12.30B | $591.4M |
| Mar 2022 | $8.16B | $11.77B | $490.8M |
| Jun 2022 | $8.00B | $11.20B | $711.3M |
| Sep 2022 | $7.64B | $10.38B | $839.4M |
| Dec 2022 | $7.75B | $10.84B | $881.5M |
| Mar 2023 | $7.71B | $11.05B | $1.17B |
| Jun 2023 | $7.73B | $11.26B | $1.28B |
| Sep 2023 | $7.71B | $11.20B | $1.34B |
| Dec 2023 | $7.66B | $11.39B | $1.51B |
| Mar 2024 | $7.63B | $11.33B | $1.44B |
| Jun 2024 | $7.60B | $11.36B | $1.36B |
| Sep 2024 | $8.08B | $12.26B | $2.22B |
| Dec 2024 | $7.92B | $12.01B | $2.41B |
| Mar 2025 | $7.36B | $11.53B | $1.86B |
| Jun 2025 | $7.24B | $10.94B | $1.19B |
| Sep 2025 | $7.40B | $11.36B | $1.33B |
| Dec 2025 | $7.34B | $11.66B | $1.39B |
| Mar 2026 | $7.33B | $11.86B | $1.84B |
| Jun 2026 | $6.28B | $11.08B | $1.62B |